Type I Hypersensitivity is a form of allergic reaction caused by the body's immune system overreacting to a foreign substance, such as pollen, pet dander, or dust mites. This reaction is mediated by immunoglobulin E (IgE) antibodies, which trigger the release of histamine and other inflammatory mediators. Symptoms of Type I Hypersensitivity can range from mild to severe, and can include sneezing, itching, hives, and anaphylaxis.
The Allergy and Immunology market is a rapidly growing field, with a focus on the diagnosis and treatment of allergic and immunologic diseases. This includes the diagnosis and treatment of Type I Hypersensitivity, as well as other allergic and immunologic conditions. Treatment options for Type I Hypersensitivity include allergen avoidance, immunotherapy, and medications such as antihistamines and corticosteroids.
Companies in the Type I Hypersensitivity market include Allergan, Merck, Sanofi, and Teva Pharmaceuticals. Show Less Read more
